Use of a commercial artificial intelligence-based mammography analysis software for improving breast ultrasound interpretations
European Radiology · 2024
DOI: 10.1007/s00330-024-10718-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Radiology, 2024. Verfasst von Hee Jeong Kim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-Ro 43-Gil, Son…. Hauptthemen laut MEDLINE: Artificial Intelligence, Breast Neoplasms, Ultrasonography, Mammary, Software. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVES: To evaluate the use of a commercial artificial intelligence (AI)-based mammography analysis software for improving the interpretations of breast ultrasound (US)-detected lesions. METHODS: A retrospective analysis was performed on 1109 breasts that underwent both mammography and US-guided breast biopsy. The AI software processed mammograms and provided an AI score ranging from 0 to 100 for each breast, indicating the likelihood of malignancy. The performance of the AI score in differentiating mammograms with benign outcomes from those revealing cancers following US-guided breast biopsy was evaluated. In addition, prediction models for benign outcomes were constructed based on clinical and imaging characteristics with and without AI scores, using logistic regression analysis. RESULTS: The AI software had an area under the receiver operating characteristics curve (AUROC) of 0.79 (95% CI, 0.79-0.82) in differentiating between benign and cancer cases. The prediction models that did not include AI scores (non-AI model), only used AI scores (AI-only model), and included AI scores (integrated model) had AUROCs of 0.79 (95% CI, 0.75-0.83), 0.78 (95% CI, 0.74-0.82), and 0.85 (95% CI, 0.81-0.88) in the development cohort, and 0.75 (95% CI, 0.68-0.81), 0.82 (95% CI, 0.76-0.88), and 0.84 (95% CI, 0.79-0.90) in the validation cohort, respectively. The integrated model outperformed the non-AI model in the development and validation cohorts (p < 0.001 for both). CONCLUSION: The commercial AI-based mammography analysis software could be a valuable adjunct to clinical decision-making for managing US-detected breast lesions. CLINICAL RELEVANCE STATEMENT: The commercial AI-based mammography analysis software could potentially reduce unnecessary biopsies and improve patient outcomes. KEY POINTS: • Breast US has high rates of false-positive interpretations. • A commercial AI-based mammography analysis software could distinguish mammograms having benign outcomes from those revealing cancers after US-guided breast biopsy. • A commercial AI-based mammography analysis software may improve interpretations for breast US-detected lesions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-Ro 43-Gil, Songpa-Gu, Seoul, 05505, South Korea.
- Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-Ro 43-Gil, Songpa-Gu, Seoul, 05505, South Korea. hhkim@amc.seoul.kr.
- Lunit Inc., 15F, 27, Teheran-Ro 2-Gil, Gangnam-Gu, Seoul, 06241, South Korea.
- Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College, Ulsan, South Korea.
Zitieren
APA
Kim, H. J., Kim, H. H., Kim, K. H., Lee, J. S., Choi, W. J., Chae, E. Y., Shin, H. J., Cha, J. H., & Shim, W. H. (2024). Use of a commercial artificial intelligence-based mammography analysis software for improving breast ultrasound interpretations. European Radiology. https://doi.org/10.1007/s00330-024-10718-3
Vancouver
Kim HJ, Kim HH, Kim KH, Lee JS, Choi WJ, Chae EY, et al. Use of a commercial artificial intelligence-based mammography analysis software for improving breast ultrasound interpretations. European Radiology. 2024. doi:10.1007/s00330-024-10718-3
BibTeX
@article{Kim2024,
author = {Kim, Hee Jeong and Kim, Hak Hee and Kim, Ki Hwan and Lee, Ji Sung and Choi, Woo Jung and Chae, Eun Young and Shin, Hee Jung and Cha, Joo Hee and Shim, Woo Hyun},
title = {Use of a commercial artificial intelligence-based mammography analysis software for improving breast ultrasound interpretations},
journal = {European Radiology},
year = {2024},
doi = {10.1007/s00330-024-10718-3}
}
EUVIMED